177 related articles for article (PubMed ID: 24654937)
1. Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.
Bonacci T; Audebert S; Camoin L; Baudelet E; Bidaut G; Garcia M; Witzel II; Perkins ND; Borg JP; Iovanna JL; Soubeyran P
J Proteome Res; 2014 May; 13(5):2478-94. PubMed ID: 24654937
[TBL] [Abstract][Full Text] [Related]
2. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
Mu GG; Zhang LL; Li HY; Liao Y; Yu HG
Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906
[TBL] [Abstract][Full Text] [Related]
4. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
5. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.
Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S
Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway.
Adesso L; Calabretta S; Barbagallo F; Capurso G; Pilozzi E; Geremia R; Delle Fave G; Sette C
Oncogene; 2013 Jun; 32(23):2848-57. PubMed ID: 22797067
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-like modifications in the DNA damage response.
Wang Z; Zhu WG; Xu X
Mutat Res; 2017 Oct; 803-805():56-75. PubMed ID: 28734548
[TBL] [Abstract][Full Text] [Related]
8. Identification of ubiquitin/ubiquitin-like protein modification from tandem mass spectra with various PTMs.
Kang C; Yi GS
BMC Bioinformatics; 2011 Dec; 12 Suppl 14(Suppl 14):S8. PubMed ID: 22373085
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry.
Duan Q; Zhao H; Zhang Z; Li H; Wu H; Shen Q; Wang C; Yin T
Sci Rep; 2017 Oct; 7(1):12891. PubMed ID: 29018223
[TBL] [Abstract][Full Text] [Related]
10. CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway.
Chen X; An Y; Zhang Y; Xu D; Chen T; Yang Y; Chen W; Wu D; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):612-619. PubMed ID: 33764366
[TBL] [Abstract][Full Text] [Related]
11. The SUMO pathway in pancreatic cancer: insights and inhibition.
Schneeweis C; Hassan Z; Schick M; Keller U; Schneider G
Br J Cancer; 2021 Feb; 124(3):531-538. PubMed ID: 33071285
[TBL] [Abstract][Full Text] [Related]
12. Phenoxodiol enhances the antitumor activity of gemcitabine in gallbladder cancer through suppressing Akt/mTOR pathway.
Li Y; Huang X; Huang Z; Feng J
Cell Biochem Biophys; 2014 Nov; 70(2):1337-42. PubMed ID: 24902539
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative Effects of Matricine in Gemcitabine-Resistant Human Pancreatic Carcinoma Cells Are Mediated via Mitochondrial-Mediated Apoptosis, Inhibition of Cell Migration, Invasion Suppression, and Mammalian Target of Rapamycin (mTOR)-TOR/PI3K/AKT Signalling Pathway.
Fang K; Wang L; Chen L; Liu T; Fang Z
Med Sci Monit; 2019 Apr; 25():2943-2949. PubMed ID: 31005960
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer.
Awasthi N; Yen PL; Schwarz MA; Schwarz RE
J Cell Biochem; 2012 Mar; 113(3):784-91. PubMed ID: 22020918
[TBL] [Abstract][Full Text] [Related]
15. Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner.
Fiorini C; Cordani M; Gotte G; Picone D; Donadelli M
Biochim Biophys Acta; 2015 Mar; 1853(3):549-60. PubMed ID: 25533084
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway.
Zhao F; Yang G; Qiu J; Liu Y; Tao J; Chen G; Su D; You L; Zheng L; Zhang T; Zhao Y
Mol Carcinog; 2022 Sep; 61(9):839-850. PubMed ID: 35785493
[TBL] [Abstract][Full Text] [Related]
18. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway.
Liu J; Huang Y; Liu Y; Chen Y
Med Sci Monit; 2019 Aug; 25():6085-6096. PubMed ID: 31412018
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
Yokoi K; Fidler IJ
Clin Cancer Res; 2004 Apr; 10(7):2299-306. PubMed ID: 15073105
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a method for profiling post-translational modification activities using protein microarrays.
Del Rincón SV; Rogers J; Widschwendter M; Sun D; Sieburg HB; Spruck C
PLoS One; 2010 Jun; 5(6):e11332. PubMed ID: 20596523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
